Literature DB >> 14630990

General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover.

Ute Spiekerkoetter1, Zaza Khuchua, Zou Yue, Michael J Bennett, Arnold W Strauss.   

Abstract

The mitochondrial trifunctional protein (TFP) is a multienzyme complex of the beta-oxidation cycle. Human TFP is an octamer composed of four alpha-subunits harboring long-chain enoyl-CoA hydratase and long-chain L-3-hydroxyacyl-CoA dehydrogenase and four beta-subunits encoding long-chain 3-ketoacyl-CoA thiolase. Mutations in either subunit may result in general TFP deficiency with reduced activity of all three enzymes. We report five new patients with alpha-subunit mutations and compare general TFP deficiency caused by alpha-subunit mutations (n = 15) to that caused by beta-subunit mutations (n = 13) with regard to clinical features, enzyme activity, mutations, thiolase expression, and thiolase protein turnover. Among patients with alpha-subunit mutations, the same three heterogeneous phenotypes reported in patients with beta-subunit mutations were observed: a lethal form with predominating cardiomyopathy; an infancy-onset, hepatic presentation; and a milder, later-onset, neuromyopathic form. Maternal HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) occurred with an incidence of 15 to 20%, as in families with beta-subunit mutations. Enzyme assays in fibroblasts revealed an identical biochemical pattern in both groups. alpha-Subunit mutational analysis demonstrated molecular heterogeneity, with 53% (9 of 17) truncating mutations. In contrast, patients with beta-subunit mutations had predominantly missense mutations. Thiolase expression in fibroblasts was as markedly reduced in alpha-subunit patients as in the beta-subunit group with similarly increased thiolase degradation, presumably secondary to TFP complex instability. TFP deficiency as a result of either alpha- or beta-subunit mutations presents with similar, heterogeneous phenotypes. Both alpha- and beta-subunit mutations result in TFP complex instability, demonstrating that the mechanism of disease is the same in alpha- or beta-mutation-derived disease and explaining the biochemical and clinical similarities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630990     DOI: 10.1203/01.PDR.0000103931.80055.06

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  28 in total

Review 1.  Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Authors:  Ute Spiekerkoetter; Philip A Wood
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

2.  Necrotizing enterocolitis and respiratory distress syndrome as first clinical presentation of mitochondrial trifunctional protein deficiency.

Authors:  Eugène F Diekman; Carolien C A Boelen; Berthil H C M T Prinsen; Lodewijk Ijlst; Marinus Duran; Tom J de Koning; Hans R Waterham; Ronald J A Wanders; Frits A Wijburg; Gepke Visser
Journal:  JIMD Rep       Date:  2012-03-31

3.  Crystal structure of human mitochondrial trifunctional protein, a fatty acid β-oxidation metabolon.

Authors:  Chuanwu Xia; Zhuji Fu; Kevin P Battaile; Jung-Ja P Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

4.  Cryo-EM structure of human mitochondrial trifunctional protein.

Authors:  Kai Liang; Ningning Li; Xiao Wang; Jianye Dai; Pulan Liu; Chu Wang; Xiao-Wei Chen; Ning Gao; Junyu Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-18       Impact factor: 11.205

Review 5.  Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies.

Authors:  Fatima Djouadi; Jean Bastin
Journal:  Cells       Date:  2019-03-28       Impact factor: 6.600

Review 6.  Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.

Authors:  Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

7.  Characterization of Chorioretinopathy Associated with Mitochondrial Trifunctional Protein Disorders: Long-Term Follow-up of 21 Cases.

Authors:  Erin A Boese; Nieraj Jain; Yali Jia; Catie L Schlechter; Cary O Harding; Simon S Gao; Rachel C Patel; David Huang; Richard G Weleber; Melanie B Gillingham; Mark E Pennesi
Journal:  Ophthalmology       Date:  2016-08-02       Impact factor: 12.079

8.  Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.

Authors:  Fatima Djouadi; Florence Habarou; Carole Le Bachelier; Sacha Ferdinandusse; Dimitri Schlemmer; Jean François Benoist; Audrey Boutron; Brage S Andresen; Gepke Visser; Pascale de Lonlay; Simon Olpin; Toshiyuki Fukao; Seiji Yamaguchi; Arnold W Strauss; Ronald J A Wanders; Jean Bastin
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

9.  Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases.

Authors:  Ryosuke Bo; Kenji Yamada; Hironori Kobayashi; Purevsuren Jamiyan; Yuki Hasegawa; Takeshi Taketani; Seiji Fukuda; Ikue Hata; Yo Niida; Yosuke Shigematsu; Kazumoto Iijima; Seiji Yamaguchi
Journal:  J Hum Genet       Date:  2017-05-18       Impact factor: 3.172

Review 10.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.